Magazine article from our research archive:

Merrion's losses double as loan charge takes toll.

Merrion's losses double as loan charge takes toll

Merrion Pharmaceuticals, the specialist in orally administered drugs which floated on Dublin's IEX late last year, has reported an increase in its operating losses in the year end to December 2007 to '5.93m, compared with just over '3m in the nine months to the end of December 2006. The pre-tax loss figure for the year was '12.08m. This included a non-cash non-recurring finance expense principally arising on convertible loan stock of '6.6m, the company said yesterday.

Commenting on the results, CEO John Lynch said: "This solid progress allows us to continue to advance our clinical programmes for those products which ...

Related newspaper, magazine, and journal articles:

See all results. Or, try our Advanced Search.

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 60 million articles! Access over 3,500 publications with a FREE trial!